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ABSTRACT 
The objective of this experiment was to investigate bovine somatotropin (bST) and 
Vitamin A as a potential treatment to enhance the number of ovarian follicles that respond to 
superovulation. During phase I, non-lactating Jersey cows were randomly assigned to one of 
four treatments (250 mg bST at Day 0, 250 mg bST at Day 8, 1 M units of Vitamin A at Day 
8, saline at Day 8 [control]). Day 0 was defined as the day of onset of estrus, and 
superovulation treatment was initiated on Day 8 of the estrous cycle. Ultrasonography was 
performed daily to monitor ovarian follicular dynamics and to determine the number of 
ovulations resulting from superovulation. Results revealed that the total number of ovarian 
follicles and superovulatory response was not different among treatments. Phase II utilized 
the same non-lactating Jersey cows used during phase I, and cows received one of three 
treatments (250 mg bST at Day 0, 250 mg bST at Day 8, saline at Day 8 [control]) prior to 
superovulation. Artificial insemination was performed, embryos were recovered, and 
embryo quality and stage of development were recorded. Data analysis revealed no effect of 
treatment on the total number of ovarian follicles or on production of transferable quality 
embryos in any of the three replicates. These results indicate that a single treatment with 250 
mg bST or 1 M units of vitamin A during the estrous cycle in which superovulation is 





Despite efforts to increase the number of ovulations and decrease variability among 
cows, inconsistency in the superovulatory response remains a serious impediment to 
successful bovine embryo transfer. Even though embryo production and transfer 
methodology have improved over the years, the main drawback is still the inability to ensure 
that a donor will provide a suitable number of viable embryos at a given time. 
Methods such as initiating superovulation treatments at the time of follicular wave 
emergence, removing the dominant follicle, or inducing a new follicular wave using 
exogenous progesterone and estradiol just prior to initiation of superovulation are used in an 
attempt to enhance the superovulatory response. However, despite these numerous different 
approaches, little progress has been made in reducing the variation in superovulatory 
response among donor cows. 
Various compounds have been investigated for their ability to enhance reproductive 
efficiency. One example is vitamin A. Vitamin A is essential for normal reproduction, and 
limited evidence exists that parenteral vitamin A may enhance reproductive function. 
Another example of a hormone known to affect bovine reproductive performance is 
bovine somatotropin (bST; also known as bovine growth hormone [bGH]). It is known that 
bST and IGF-1 (insulin-like growth factor-I) are increased in the blood ofbST-treated cows. 
Administration of exogenous bST stimulates production of IGF-1, a potent mitogen that 
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increases granulosa cell growth in the bovine ovarian follicle. It is believed that bST may act 
directly on the ovary to change reproductive function independently of energy balance. 
Our hypothesis was that treatment of cows with exogenous vitamin A or bST would 
alter folliculogenesis, resulting in a better superovulatory response and consequently a 
greater number of transferable quality embryos. 
Thesis Organization 
This thesis begins with a review of the literature and contains a general explanation of 
the following topics: embryo transfer, ovarian follicular development, follicular waves, 
endocrine control of follicular waves, superovulation, typical superovulation methods, use of 
somatotropin to enhance superovulation, the effect of bST on reproductive performance in 
cattle, and the use of vitamin A to enhance superovulatory response. These topics were 
included to give a general understanding of the background and purpose of the thesis study 
described herein. 
Following the literature review is one manuscript prepared for publication in a 
scientific journal. The manuscript describes an experiment involving dairy cows treated with 
bST, Vitamin A or saline with the goal of enhancing the number of FSH-receptive follicles at 
the initiation of superovulation. 
The thesis finishes with a general conclusion chapter which contains a discussion of 
the results of the experiment and their implications on the potential to enhance 




Embryo transfer is a series of related procedures that includes the collection of 
embryos from a genetically outstanding female (the donor) and subsequent transfer of the 
harvested embryos to other females of lesser genetic merit (the recipients). Non-surgical 
embryo recovery procedures, combined with non-surgical embryo transfer and embryo 
freezing and thawing methods, became available in the early 1980s and have been used ever 
since (Merton et al., 2003). The primary purpose of embryo transfer is to propagate superior 
genetics from a small group of females, thereby increasing the rate of genetic improvement. 
The technique involves synchronization of estrus, superovulation, detection of estrus and 
breeding in addition to embryo collection and embryo transfer. 
Synchronization of estrus is an important procedure that allows matching of the stage 
of the estrous cycle in the recipients to the stage of the estrous cycle of the donor, a critical 
step toward maximizing pregnancy rates obtained via embryo transfer. In cattle the ideal 
situation to maximize pregnancy rate following embryo transfer is when the recipient is in 
estrus at any time between 12 hours before the donor female to 24 hours after the donor. 
superovulation is a procedure used to increase the number of ovulations and 
subsequently the number of viable embryos possessing a high probability of establishing a 
pregnancy after transfer (Kafi and McGowan, 1997; Mapletoft et al., 2002). 
Detection of estrus is one of the most important steps in the embryo transfer 
procedure because, upon completion of superovulation, the ovulated oocytes must be 
fertilized to enable the production of viable embryos. Fertilization of the ovulated ova 
typically is accomplished through artificial insemination at a set time (approximately 12 and 
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24 hours) after the detection of estrus. Thus, if the estrus goes undetected, insemination will 
not be performed and embryos will not be produced. 
The collection of embryos from the donor cow is accomplished non-surgically by 
flushing the uterus with sterile medium. The flush should be performed 5-8 days after the 
first breeding. This gives time for the embryos to leave the oviduct and arrive in the uterus, 
but embryos are recovered before they begin to hatch from their zonae pellucidae. 
After the embryos are recovered, they are transferred individually to the uterus of a 
recipient cow that, if confirmed pregnant, will carry the conceptus to term. The birth of 
genetically valuable offspring is the culmination of the embryo transfer process. 
Ovarian Follicular Development 
A reproductively healthy female is born with all of the oocytes (around 150,000) in 
her ovaries that she will possess during her lifetime (Erickson, 1966). After puberty females 
begin exhibiting reproductive (estrous) cycles consisting of growth of ovarian follicles, 
ovulation, formation of luteal structures, and termination of luteal structures either in the 
absence of pregnancy or at the cessation of pregnancy. The population of ovarian follicles 
changes continually throughout the estrous cycle, and these changes are referred to as 
follicular dynamics. The understanding of follicular dynamics was facilitated after the 
introduction of transrectal ultrasonic imaging for the study of bovine ovarian follicles 
(Pierson and Ginther, 1984). Ovarian follicles have been classified by scientists studying 
follicular dynamics as small, medium and large depending on their diameter (Senger, 2003). 
There are four basic processes that encompass the changes that comprise ovarian 
follicular dynamics-- recruitment, selection, dominance, and atresia. Recruitment refers to 
the process where follicles are "recruited" (from the large pool of ovarian antral follicles) in a 
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group known as a cohort. Selection is a process whereby some of the cohort follicles are 
"selected" to continue further growth/development. Those follicles that are not selected will 
die in a process called atresia. In cattle, typically one of the selected follicles will become 
"dominant" (develop into an ovulatory-sized follicle) while the remaining follicles undergo 
atresia. Ultrasonic monitoring of bovine follicles from day to day confirmed these 
interpretations (Fortune et al., 1988; Pierson and Ginther, 1988; Savio et al., 1988). 
Ovarian follicles develop sequentially. Folliculogenesis is controlled by complex 
relationships between intrafollicular steroids, growth factors, extra ovarian factors and the 
hypothalamo-pituitary-ovarian feedback system (Campbell et al., 1995). Folliculogenesis in 
the cow is a process that encompasses the growth of primordial stage follicle to ovulatory-
sized follicles. Primordial follicles (the least developed and most numerous type of follicle) 
will develop into primary follicles, although some of them will die (undergo atresia). The 
same developmental process occurs with primary follicles: some will become secondary 
follicles, and some will undergo atresia. Once ovarian follicles reach the secondary stage of 
development they become responsive to gonadotropic hormones, especially follicle 
stimulating hormone (FSH). Thus, superovulation protocols using FSH target secondary and 
more advanced ovarian follicles. The secondary follicles will also either undergo atresia or 
develop into antral follicles. Antral follicles of various sizes develop in response to tonic 
levels of FSH and luteinizing hormone (LH). Large, ovulatory-sized follicles are also known 
as Graafian follicles. 
Follicular waves 
Some investigators concluded that there are two or three follicular growth waves 
during the bovine estrous cycle-- one starting at estrus (day 0= day of the estrus) and the 
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second around day 8 of the estrous cycle in a two-wave animal, and follicular waves starting 
on days 2, 9 and 16 of the estrous cycle in three-wave cows (Pierson and Ginther, 1988; 
Sirois and Fortune, 1988). The factor that determines if an animal will have two or three 
follicular waves is the time of luteolysis relative to the time of appearance of the second 
follicular wave (Fortune, 1993). Each wave grows by recruitment of a cohort of follicles 4 to 
5 mm in diameter that start growing and producing estradiol (Bao and Garverick, 1998). 
This suggests that they receive a signal that allows them to grow and develop rather than 
regress (Fortune, 1994). This signal maybe related to the slight elevation of plasma FSH 
(Adams et al., 1992). The presence of FSH receptors has been implicated in the recruitment 
process (De la Sota et al., 1996) and there seems to be a correlation between the increase of 
plasma FSH and the growth of the cohort of ovarian follicles. From the cohort, one follicle 
will continue growing (Adams et al., 1993; Mihm et al., 1997) and become dominant, 
inhibiting the growth of other follicles (Ginther, 2000) and causing them to undergo atresia 
(Bao and Garverick, 1998). The dominant follicle will regress if it reaches maximum size 
during the luteal phase of the estrous cycle, but it will ovulate after luteal regression if it is 
the dominant follicle of the second wave of two-wave females (Ginther et al., 1989). 
It has been suggested that those follicles which begin to respond to gonadotropic 
hormones and which can coordinate gene expression of growth factors, steroidogenic 
enzymes and inhibins will be selected (Erickson et al., 1994; Evans and Fortune, 1997; 
Fortune, 1994; Ginther, 2000). 
When a bovine dominant follicle is a little larger in size than the largest subordinate, 
it can produce more estradiol and inhibit the subordinate follicles of the same cohort. It can 
also maintain low systemic FSH concentration, presumably via inhibin, to prevent growth of 
7 
any other follicles (Evans and Fortune, 1997). Growth and estradiol synthesis of the first 
dominant follicle of the cycle usually does not occur for more than 3-4 days, as the 
developing corpus luteum (CL) secretes progesterone which negatively regulates the LH 
pulse pattern and causes the LH-dependent dominant follicle to become atretic (Evans and 
Fortune, 1997). The initial decline in estradiol secretion on day 6 is followed by stasis and 
loss of dominance between days 7 and 9, transient FSH rise, wave emergence, and selection 
of a new dominant follicle while the old dominant follicle regresses (Sunderland et al., 1994). 
If luteolysis occurs during the phase of dominance of the second dominant follicle, then the 
second dominant follicle will ovulate. If the corpus luteum is still active when the second 
dominant follicle (DF) reaches maximum size, the third wave will emerge giving rise to the 
third dominant follicle (Cooke et al., 1997). Following regression of the corpus luteum, a 
frequent LH pulse pattern supports the second (or third) dominant follicle which can now go 
through differentiation, induce the gonadotropin surge and ovulate (Mihm et al., 2002). 
Endocrine control of follicular waves 
The hypothalamus is the neural control center for reproductive hormones, and it 
consists of three regions (the surge center, tonic center and paraventricular nucleus) that have 
a direct effect on reproduction (Senger, 2003). Neurons in the surge and tonic centers 
produce gonadotropin releasing hormone (GnRH), whereas the hormone oxytocin is 
synthesized by the paraventricular nucleus. 
Gonadotropins are hormones released by the gonadotroph cells of the anterior 
pituitary gland in response to GnRH released from the hypothalamus, and gonadotropins 
stimulate the gonads. The major gonadotropins are FSH and LH. Luteinizing hormone is 
responsible for causing ovulation and stimulating the CL to produce progesterone. Follicle 
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stimulating hormone causes follicular growth in the ovaries of a female (Senger, 2003). 
During follicular growth, LH binds to LH-specific membrane receptors located on the theca 
interna of the developing follicle and activates a cascade of intracellular events. Cholesterol 
is converted into testosterone, and testosterone diffuses out of the theca interna and enters the 
granulosa cells where it is converted to estradiol when FSH binds to its receptor. When 
estradiol reaches its threshold, the preovulatory LH surge is induced. The preovulatory LH 
surge is an important event because it leads to ovulation of the dominant follicle (Senger, 
2003). 
Positive and negative feedback control the secretion of GnRH which in turn controls 
the secretion of FSH and LH. The surge center of the hypothalamus releases a large amount 
of GnRH when there is a positive feedback from estradiol (produced by antral follicles) and 
progesterone levels are low. The GnRH surge induces a large release of LH that stimulates 
ovulation of the dominant follicle. The tonic center releases small amounts of GnRH 
frequently, and it responds to negative feedback of estradiol produced by antral follicles and, 
to a much lesser extent, progesterone produced by the CL (Senger, 2003). 
It is known that several growth factors stimulate bovine granulosa cells and 
steroidogenesis, including IGF-I (Echternkamp et al., 1994). The IGFs (also called 
somatomedins) are polypeptide growth factors secreted by the liver and several other tissues 
in response to stimulation by growth hormone. They mediate most of the growth-promoting 
actions of growth hormone, regulate proliferation and differentiation of several cell types, 
and exert insulin-like metabolic effects (Jones and Clemmons, 1995). The IGFs are widely 
synthesized locally and have paracrine and autocrine as well as endocrine actions in tissues 
(Jones and Clemmons, 1995). Although the precise mechanisms are not known, the 
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observations that the intraovarian IGF-I system can regulate the response of granulosa and 
theca cells to gonadotropins suggests that IGF-I mediates the effects of metabolic hormones 
on ovarian function (Armstrong and Childs, 1997). 
The IGF-I system (receptors, ligands, and binding proteins for both IGF-I and IGF—II) 
maybe what controls follicular development, and it is expressed within granulosa and theca 
cells (Poretsky et al., 1999). The IGFs, acting with gonadotropins, seem to be involved in 
promoting differentiation of ovarian follicular cells (Giudice, 1992). The cell-specific pattern 
of IGF gene expression, however, depends on the developmental stage of the follicle (Lucy, 
2000). IGF-I binds to its receptor through one of six high-affinity IGF binding proteins (IGF 
binding proteins 1 through 6; Giudice, 1992). Binding of IGF to IGF binding proteins 
(IGFBP) inhibits the binding of an IGF to its receptor and thus inhibits IGFs effects on 
gonadotropin-induced follicular growth and differentiation (Giudice, 1992). 
The most important actions of ovarian IGF are observed when IGF acts 
synergistically with the gonadotropins (either FSH or LH) to impact a variety of cellular 
functions including mitogenesis and steroidogenesis (Gutierrez et al., 1997). The synergism 
is caused by the ability of IGF to increase the activity of gonadotropin receptor second 
messenger system (Giudice, 1992). At the same time gonadotropins increase type I IGF 
receptor expression and IGF-I synthesis in granulosa cells (Spicer and Echternkamp, 1995). 
In addition to being an active site of IGF-I and —II synthesis and secretion, the ovary 
also synthesizes, secretes and degrades IGFBP (Adashi, 1994). The levels of IGFBPs in 
follicular fluid are dependent on the functional status of the follicle (Irving-Rodgers et al., 
2003). In bovine follicles, the total levels of IGFBPs are present in lower concentration in 
larger follicles (Echternkamp et al., 1994). For atretic bovine follicles, follicular fluid has 
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elevated levels of IGFBPs in comparison with the follicular fluid of healthy follicles 
(Echternkamp et al., 1994). Indeed, the response of the ovary to IGF may ultimately depend 
on the net effect of IGFBP rather than on the absolute concentration of IGF because the 
concentrations of IGF-I and —II in follicular fluid do not change markedly during follicular 
growth and development (De la Sota et al., 1993). The IGFBPs may prevent IGF from 
binding to receptors located within the granulosa cells and, therefore, prevent further growth 
or differentiation in follicles undergoing atresia (Lucy, 2000). 
Proteolytic enzymes are present in follicular fluid ofestrogen-active dominant 
follicles (Besnard et al., 1997). The IGFBP proteases degrade IGFBPs, thereby causing a 
lower concentration of IGFBP in follicular fluid (Lucy, 2000). Proteolytic activity of 
IGFBP-4 protease reduces IGF binding to IGFBP-4, and that is thought to be one of several 
mechanisms by which estradiol-dominant healthy follicles have a higher bioavailability of 
IGF (Irving-Rodgers et al., 2003). Dominant follicles have an IGFBP-4 proteastic activity 
that is not found in subordinate follicles of the same cohort (Rivera et al., 2001). Protease 
activity is detected very early in follicular growth and persists throughout preovulatory 
development, suggesting that IGFBPs and proteases are related to the fate of the follicle 
(Rivera et al., 2001). It seems that IGFBP-4 protease has a critical role in the establishment 
of dominance of follicles in cattle, reducing intrafollicular levels of IGFBP-4 and providing 
more available IGFs to support continued growth and development of the selected follicle in 
response to FSH (Rivera et al., 2001). 
IGF-I and FSH stimulate aromatase and thus promote continuing follicle growth and 
estradiol synthesis (Fortune et al., 2001). A subsequent decrease in bioavailable IGF-I in a 
low-FSH environment may cause a loss of aromatase activity and initiate regression of 
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subordinate follicles (Silva and Price, 2002). While it has been shown that IGF-I and insulin 
stimulate estradiol secretion in several cell culture systems, it is not known whether the 
decrease in free IGF-I observed in vivo is a cause of early follicle regression and decrease in 
aromatase activity (Silva and Price, 2002). 
superovulation 
The efficiency of bovine embryo transfer can be increased considerably by 
administering gonadotropic hormones that act on the ovaries of the donor females to induce 
ovulation of multiple oocytes. The principle of superovulation is based on bypassing the 
mechanism of follicular selection by administration of exogenous gonadotropic hormones at 
the time that a new cohort of follicles is being recruited, preventing atresia in follicles >1.7 
mm in diameter and leading to an increase in the number of follicles that have potential to 
become ovulatory-sized (Monniaux et al., 1983). 
In a non-superovulated female, typically only one follicle ovulates. If the ovulated 
oocyte was fertilized and embryo recovery was performed in that cow, a maximum of one 
embryo could be expected at the time of embryo collection. During each estrous cycle, 
however, approximately 20 to 30 follicles are stimulated to enter early stages of growth in 
follicular waves (Fortune, 1993), even though only one of those follicles typically ovulates. 
A relatively high proportion of those follicles has the potential to proceed to ovulatory-sized 
(D'Occhio et al., 1999), and the goal of superovulation is to stimulate the continued 
development of such follicles. 
superovulation can cause the production of multiple ovulatory-sized follicles through 
at least three different ways: 1) enhance the number of follicles in the cohort, 2) reduce 
atresia of follicles in the cohort (Moor et al., 1984), or 3) delay or prevent the selection of the 
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dominant follicle. Exogenous gonadotropins should be capable of preventing or reversing 
the process of atresia, and a reduction in atresia of follicles (within the class of 1.7 mm in 
diameter) leads to an increase in the number of follicles that respond to superovulation (Moor 
et al., 1984). 
Several approaches have been used to prevent the influence of the dominant follicle. 
One approach is to start the superovulation treatment before the selection of the dominant 
follicle on Day 8 to 9 of the estrous cycle during the emergence of the second follicular wave 
(Goulding et al., 1990). Another approach is to induce ovulation of the dominant follicle with 
GnRH prior to the start of superstimulation (Kohram et al., 1998). After the dominant follicle 
was induced to ovulate (indirectly) by GnRH, a new follicular wave was induced and an 
improved superovulatory response was obtained. Yet another approach is to remove all 
follicles >5 mm in diameter (including the dominant follicle) on Day 8 by transvaginal 
ultrasound-guided follicle puncture (Vos et al., 1994). 
The yield and quality of embryos produced after superovulation are variable and 
unpredictable owing to variation in ovarian response, fertilization rate and embryo 
development. One report from a commercial embryo transfer company in the United States 
revealed that 984 superovulated Holstein cows averaged 5.1 transferable quality embryos 
(Hasler, 1992). A subsequent report from the same firm indicated that 6000 Holstein females 
superovulated during a 13 year period produced a range of 0 to 101 ova and 0 to 50 embryos 
(Hasler, 1992). Thibier (2004) reported that the average number of transferable quality 
embryos (TQEs) per superovulated donor was six. 
Many hormonal combinations and injection schedules have been investigated for 
superovulation of cattle (Donaldson, 1984). However, variation in response among animals 
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is found in all superovulatory regimens (Monniaux et al., 1983). Genetic difference among 
animals, day of the estrous cycle that superovulatory treatment is initiated, amount of FSH 
used, purity of the superovulatory product (FSH:LH ratio), consistency and interval between 
injections, site of administration, and other factors influence the success of the 
superovulation treatment (Monniaux et al., 1983). 
Typical superovulation Methods 
Numerous attempts to improve the superovulatory response by using different 
gonadotropin preparations and/or treatment schedules have achieved limited success in 
increasing the ovulation rate and number of TQEs recovered, but none of these approaches 
was able to reduce the variability in the response (Armstrong, 1993). 
There are two glycoprotein hormones that are commonly used to induce multiple 
ovulations. FSH is a hormone released from the anterior pituitary gland to induce follicular 
growth. The half life of FSH in the cow is short (Laster, 1972), so the hormone has to be 
administered at least two times per day in order to maintain elevated blood levels of FSH. 
Pregnant mare serum gonadotropin (PMSG), now called equine chorionic 
gonadotropin (eCG), is produced by the equine placenta. eCG exhibits FSH-like activity, 
and it has ahalf--life of 40 h in the cow and persists in the bovine circulation for up to 10 days 
(Dieleman and Bevers, 1993). It maybe given as a single injection because of its long half-
life. 
Much of the early research on bovine superovulation involved the use of eCG. 
However, one of the main drawbacks to eCG use is that it gives an excessive number of 
unovulated follicles. A second problem is the antigenicity of eCG in cattle, leading to poorer 
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superovulatory responses with repetitive use (Drion et al., 2001). Although eCG is still used 
to a limited extent today, it is usually used at low levels in conjunction with FSH. 
A higher ovulatory response was obtained with FSH than with eCG (Elsden et al., 
1978). Most research since that time has utilized FSH as the gonadotropin for superovulation 
(Hasler, 1992). A potential problem with FSH has been the amount of LH present in the 
FSH preparations used for superovulation (Hasler, 1992). Commercially available FSH 
products are pituitary extracts from domestic animal species, and they contain variable 
amounts of FSH and LH (Hasler, 1992). The FSH: LH ratio in one commercial product 
varied over a 20- fold range among different production lots (Lindsell et al., 1986). Some 
LH is necessary for a better result in superovulation, but when the concentration of LH 
increases too high it results in a lower superovulatory response (Hasler, 1992). 
Typically, FSH is administered to cattle in a descending dose regimen for 4 days 
starting on day 8-10 of the estrous cycle. There are four products commercially available in 
the U.S. for superovulation of cattle: Folltropin®, Pluset®, OvagenTM and Embryo S®. 
Folltropin® and Pluset® are manufactured using porcine anterior pituitary glands as the as 
source of FSH, whereas Embryo S® and OvagenTM are extracted from ovine anterior 
pituitary glands. 
Although exogenous gonadotropin treatment can induce superovulation (Monniaux 
et al., 1983), the mechanisms controlling ovulation rate are not fully understood. Attempts to 
enhance ovulation rate have been performed by several researchers who utilized, among 
other, techniques, immunization against gonadal steroids, dominant follicle removal, change 
in the amount of FSH dose, change in FSH product, treatment with bST, administration of 
vitamin A, etc. 
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Use of somatotropin to enhance superovulation 
Somatotropin is an anterior pituitary hormone that controls animal growth, nutrient 
metabolism and reproductive function (Etherton and Bauman, 1998). The hypothalamus, 
pituitary gland, CL, ovarian follicle, oviduct, endometrium, myometrium, and placenta all 
have somatotropin receptor mRNA (Heap et al., 1996). If the somatotropin receptor mRNA 
is translated to protein, then somatotropin can bind to its receptor and exert effects in all 
tissues of the reproductive system (Lucy, 2000). Within an animal the tissue with the 
greatest amount of somatotropin receptor is the liver, and the receptor number on the liver 
exceeds that in reproductive tissue by several fold (Lucy et al., 1998). In addition to 
changing metabolism in the liver, somatotropin increases the synthesis and secretion of IGF-I 
and IGFBP (Jones and Clemmons, 1995). 
The bovine ovary can respond directly to somatotropin because somatotropin 
receptors are found in the ovarian cells (Lucy, 2000). Somatotropin receptor mRNA was 
detected in bovine granulosa cells, cumulus cells and the oocyte (Izadyar et al., 1997). 
Expression of the somatotropin receptor was greatest in oocytes from primordial and primary 
follicles (Lucy, 2000). In antral follicles, the greatest amount of somatotropin receptor 
expression was found in the cells of the cumulus oophorus (Kolle et al., 1998). Because 
somatotropin receptors were found in preantral follicles and cumulus cells, it suggests that 
somatotropin is involved in follicular growth and development (Lucy, 2000). Farm and 
laboratory animals with increased concentrations of somatotropin have greater blood 
concentration of IGF-I and greater ovarian follicular development (De la Sota et al., 1993). 
Recombinant bovine somatotropin (rbST) is a synthetically derived hormone that is 
structurally similar to naturally produced bovine growth hormone (Dohoo et al., 2003). In 
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1993, sometribove (Posilac"; Monsanto Corporation, St. Louis, Missouri, USA) was 
approved for use in the United States, but the product was not actually sold commercially 
until 1994 (Dohoo et al., 2003). The administration of rbST was first shown to increase milk 
production (Bauman, 1992), but later it was found to impact cow fertility, sometimes 
negatively (Rieger et al., 1991) and sometimes positively (Moreira et al., 2002). 
The levels of bST and IGF-I are increased in the blood ofbST-treated cows, and bST 
treatment may act directly on the ovary to change reproductive function (Adashi et al., 1985). 
Follicular development is influenced not only by FSH and LH but also by GH and IGF-I 
(Pavlok et al., 1996). Injections of bST increased the levels of GH, IGF-I and insulin within 
24, 48 and 72 h, respectively (Gong et al., 1993). In addition, rbST changed patterns of 
ovarian follicular growth and development by causing premature loss of dominance in 
dominant follicles (Lucy, 2000). The number of recruited follicles increased in cows or 
heifers that were either injected daily with rbST or treated with asustained-released rbST 
formulation (Gong et al., 1997). Increased numbers of dominant follicles and increased 
ovulation rate were found in dairy cattle infused for 63 d with pulsatile doses of bST 
(Jimenez-Krassel et al., 1999). 
The increase in follicular development after rbST treatment may be a direct effect 
of rbST on the follicle mediated through receptors located in the cumulus cells (Lucy, 2000). 
Alternatively, greater IGF-I concentration in the blood or changes in nutrition that may have 
occurred after rbST treatment may alter patterns of follicular development (Lucy, 2000). 
Bovine oocyte development in vitro was improved by somatotropin treatment (Izadyar et al., 
1997). However, heifers treated with increasing doses of somatotropin failed to have greater 
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growth of antral follicles when the somatotropin dose was below the threshold for the 
increased IGF-I (Gong et al., 1997). 
Twelve Hereford X Friesian heifers received daily injections of 25 mg bST or saline 
(control group) for a period of two estrous cycles. At the end of treatment on day 7 of the 
third estrous cycle, the heifers were euthanized and the ovaries were collected to count the 
number of follicles and CL. Results revealed that bST treatment increased the population of 
antral follicles 2-5 mm in diameter but did not alter ovulation rate (Gong et al., 1991). 
To investigate one potential approach to improve superovulatory regimens in cattle, 
Hereford X Friesian beef heifers were treated with 320 mg sustained-release rbGH or 10 ml 
of saline solution on day 7 of the cycle, and 5 days later received adecreasing-dose regimen 
of twice daily injections of FSH for 4 days. Embryos were recovered nonsurgically on day 6 
to 8, and ovulation rate was assessed on day 9 by laparoscopy. Treated heifers exhibited an 
increased number of small antral follicles (2 to 5 mm) on day 9, an enhanced superovulatory 
response to FSH, an improved quality of embryos, and a reduced incidence of poor responses 
compared with control heifers (Gong et al., 1996). 
Holstein heifers superovulated with twice daily injections of FSH combined with 20 
mg i.m. of rbST were utilized for non-surgical embryo collection at Day 7. Co-treatment 
with rbST increased the ovulatory response on Day 7 and increased plasma progesterone 
concentrations on Day 6. However neither the total number of embryos nor the number of 
transferable quality embryos was significantly affected by rbST treatment (Rieger et al., 
1991). 
Non-lactating Holstein and Jersey cows received 2 ear implants of estradiol-17 ~3 for 
approximately 74 d and twice per week injections of 500 mg of bST in a 2x2 factorial 
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treatment arrangement (Cushman et al., 2001b). Cows were superovulated with FSH 
beginning 2 days after the removal of the implants, and PGF2a was given on the third day of 
FSH treatment to induce ovulation. Ovaries were collected for CL count 1 to 2 weeks after 
cessation of FSH treatment. The number of CL was increased by the estradiol and bST 
combination. In a companion study, Angus cows and heifers were treated with ear implants 
of estradiol and injected biweekly with 500 mg of bST or saline. Cattle were inseminated at 
estrus, and embryos were collected 6 to 8 d later. Estradiol treatment increased the number 
of CL, and bST treatment increased the number of total ova and embryos (Cushman et al., 
2001b). 
Three experiments investigating the impact of bST treatment on follicular IGF-I 
content and ovarian response of Holstein crossbred dairy cows were conducted (Herrler et 
al., 1994). A total of 81 animals was superovulated with eCG on day 9 of the estrous cycle, 
followed by treatment with a prostaglandin Fla analogue on day 11, and artificial 
insemination on day 13. Animals received bST (640 mg) or vehicle (control) on days 4 
(before eCG) or 13 (after eCG) of the estrous cycle. In experiment 1, four or five animals 
were harvested on each of days 4, 8, 11, 13, 17 of the estrous cycle, and the follicular fluid, 
endometrial tissue and plasma were collected. In experiment 2, 38 animals received bST or 
vehicle on day 4 of the estrous cycle and animals were superovulated and flushed after 
artificial insemination (AI). In experiment 3, rbST or vehicle was administered to 21 animals 
at the time of AI on day 13. Cows treated in experiment 1 with bST on day 4 or 13 had an 
increased IGF-I content in follicular fluid, endometrial tissue and plasma. Early treatment 
(day 4) with rbST improved the superovulation rate via an increase in the number of follicles 
>4 mm in size at estrus and more transferable embryos 7d later. In experiment 2 the total 
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number of ova and embryos tended to be higher in the rbST than the control group (7.2±1.6 
vs. 5.1 ±1.1), and the number of transferable quality embryos was higher in the bST-treated 
group compared with the control group (4.2 ±1.0 vs. 2.5± 0. 7). However, in experiment 3 
the superovulatory response of animals treated with bST on day 13 did not differ from that of 
the controls. 
Lactating and non lactating superovulated Holstein donors were treated 
subcutaneouly with 500 mg of bST at the time ofpost-superovulation insemination. Animals 
received 2.5 mg estrogen, 50 mg of progesterone and two progestin implants on Day 0, and 
superovulation treatment started on day 4. Cows received PGF2a on day 6-7, and progestin 
implants were removed on day 7. Animals received a single injection of bST (500 mg) at 
insemination. Embryos were nonsurgically collected 7 days after AI and were frozen in 
ethylene glycol for direct transfer into lactating Holstein recipients that received 0 or 500 mg 
bST treatment one day after estrus. Treatment with bST at AI decreased the number of 
unfertilized ova, increased the percentage of transferable quality embryos and stimulated 
embryonic development to the blastocyst stage. Pregnancy rates following embryo transfer 
were 26% for control-recipient/control-embryo, 43%for bST-recipient/control embryo, 56% 
for control-recipient/bST-embryo and 43%bST-recipient/bST-embryo (Moreira et al., 2002). 
A total of 32 Holstein heifers was treated with 500 mg of rBST or vehicle at day 4 of 
the estrous cycle (7 days before starting the superovulation treatment), at day 11 with the first 
FSH injection, or at day 15 (at the time of artificial insemination; Kuehner et al., 1993). 
Embryos were collected nonsurgically at day 7 after AI. Heifers treated with somatotropin at 
day 11 had a higher mean number of CL than controls (18.1 vs. 13.4). Day 4 treatment 
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tended to increase the mean number of CL (15.4) and increased the overall percentage of 
TQE (74.6 vs. 58.6%). 
Ovarian function in lactating (60 to 100 d postpartum) and nonlactating (> 400 d 
postpartum) dairy cows that were injected daily with rbST during two estrous cycles was 
studied (De la Sota et al., 1993). Ultrasonography was performed to quantify follicular 
growth, and blood was collected for hormone assays. IGF-I, progesterone and estradiol in 
plasma were greater in nonlactating cows than in lactating cows. Treatment with rbST 
increased the number of follicles (6 to 15 mm) in lactating cows as well as the size of the 
second largest ovarian follicle in both nonlactating and lactating cows. 
The effect of bST on reproductive performance of cattle 
Lactating dairy cows were tested for the effect of interaction of dietary energy and fat 
with recombinant bST (sometribove) on ovarian function. Eighteen Holstein cows (60 to 100 
d into lactation) were fed three different diets with different energy concentrations and 
percentages of dry matter. Cows were synchronized with CIDRs and PGF2a and were 
injected daily with bST (25mg) or phosphate buffered saline (PBS) during each of two 19-
day experiments. Ovarian follicles were measured by ultrasonography each day. Results 
showed that bST treatment increased the number of small follicles (3-9 mm) but did not 
increase the number of medium follicles (10 to 15 mm) or follicles larger than 15 mm prior 
to day 12 of the cycle (Lucy et al., 1993). 
Lactating dairy cows were divided into two groups based on the presence or the 
absence of ovarian cysts. Cows without cysts were synchronized with OvSynch (Pursley et 
al., 1995) whereas cows with a cyst received GnRH on Day 0 and OvSynch starting 7 days 
later. Cows in both groups were artificially inseminated. Beginning on postpartum days 60 to 
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63 cows received with bST every 14 days for the duration of the study, which was actually 
initiated after bST injections began. A decreased interval from bST injection to the initiation 
of the study had a positive effect on conception rate of cows without an ovarian cyst, but a 
decreased interval from bST injection to both Day 0 and 7 had no effect on conception rate of 
cows with an ovarian cyst. An injection of bST had a beneficial effect on the preovulatory 
follicle and/or the oocyte in dairy cows without an ovarian cyst but not in cows with ovarian 
cysts (Bartolome et al., 2002). 
Lactating Holstein cows were assigned to daily treatment with bST (25mg/day) or 
placebo, beginning about 35 and 70 days postpartum and continuing unti1200 days 
postpartum. Cows received 25 mg of PGF2a on day 30 or 65 postpartum (five days prior to 
bST or placebo treatment). Follicular dynamics were examined via daily ultrasound. Luteal 
life span, length of the follicular phase and diameter of the largest follicle were not affected 
by treatment with rbST (Schemm et al., 1990). 
The effect of long term treatment with estradiol (E2) and bST on the earliest stages of 
folliculogenesis was studied in nonlactating Holstein and Jersey cows (n=26). Animals were 
treated in a 2 X 2 factorial treatment arrangement with E2 (two Compudose°  ear implants 
containing 24 mg of E2, Elanco Products Co. Indianapolis, IN.) and 500 mg of bST. 
Treatments consisted of: control-saline every 2 weeks and sham implants; bST-bST every 2 
weeks and sham implants; E2-saline every 2 weeks and two ear implants of Compudose®; 
bST + E2-bST every two weeks and two Compudose°  ear implants. The ovary contralateral 
to the corpus luteum was removed on day 8 after estrus. The E2 implants were in for 
approximately 67 d, and they were removed at time of hemi-ovariectomy. At the primary 
follicle stage the combination of bST and E2 decreased apoptosis. Estradiol induced 
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activation of follicles, bST enhanced survival of follicles, and the combination lowered 
follicular atresia (Cushman et al., 2001 a). 
Follicular growth and quality of oocytes in heifers and cows were investigated after 
treatment with a single injection of a depot form of rbST (SOOmg) given at the time of 
synchronization of estrus (day 0). Three days after rbST treatment animals were harvested 
and ovaries were dissected. After approximately 26 hours of follicle culture the oocytes had 
developed to the metaphase stage of the second meiotic division (MII). The number of 
follicles that developed in the experimental and control groups was similar, but differences 
were found in the proportion of healthy oocyte-cumulus complexes (OCC) and oocytes 
maturing from treated versus control group females. It was concluded that bST (at day 3) 
positively affected the proportion of OCC and oocytes maturing to MII (Pavlok et al., 1996). 
In another study, 26 lactating Holstein cows received saline or 500 mg of bST 
injected every 14 days (group 1: 7 injections of saline; group 2: 7 injections of bST; group 3: 
3 injections of bST and 4 injections of saline; and group 4: 3 injections of saline and 4 of 
bST). Compared with controls, cows treated with bST had a similar pattern of follicular 
growth but tended to have more 3 to 5 mm follicles and had more 6 to 9 mm follicles. There 
were no differences in the long term (7 injections) or short term (3 or 4 inj ections) effect of 
bST on ovarian function. Treatment with bST increased the number of follicles <10 mm in 
diameter, changed the timing of the second follicular wave, and decreased serum FSH 
concentrations (Kirby et al., 1997). 
The impact of 500 mg of bST on pregnancy rate to timed artificial insemination and 
on efficiency of a resynchronization system was tested in Holstein cows (n=403). Cows 
received an initial treatment with bST or saline approximately d 63 or d105 postpartum, and 
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animals were reinjected every 14 d until 30 d before the dry period. Cows were 
synchronized using the Ovsynch protocol and were artificially inseminated. If cows did not 
become pregnant to the timed AI they were reinseminated at detected estrus (RIDE) or 
resynchronized (RESYNCH). The four experimental groups evaluated were: RIDE-saline, 
RIDE-bST, RESYNCH-saline and RESYNCH-bST. Results revealed that first service 
pregnancy rates were increased in cows not resynchronized that initiated bST treatment at 63 
d postpartum compared with the cows that initiated treatment at 105 d postpartum; however, 
there was no effect of bST treatment when cows were resynchronized (Moreira et al., 2000). 
Lactating Holstein cows (n= 543) were assigned to the OvSynch synchronization 
protocol at approximately d 63, 73, and 147 postpartum in a study investigating the effect of 
presynchronization and treatment with 500 mg bST on pregnancy rate to timed AI (TAI). 
Approximately half of the animals received a presynchronization treatment that consisted of 
two injections of PGF2a given 14 days apart at approximately 37 and 51 days postpartum. 
The remaining cows received no presynchronization treatment. Twelve days after the second 
PGF2a injection of presynchronization treatment, experimental animals were started on the 
TAI protocol with an injection of GnRH. Cows received an injection of PGF2a 7 d later, an 
injection of GnRH 48 h after that, and TAI was performed 16 to 20 hours after the second 
GnRH. A group of cows (bST63) received their first injection of bST at 63d post partum 
when the first dose of GnRH dose was administered. A second group (bST73) initiated bST 
treatment at 73 d post partum when cows received their first service as a timed insemination. 
After TAI (day 0= day of insemination) cows were examined for pregnancy at day 32 and 
reexamined at day 74. The six experimental groups evaluated were: control-bST 63; control-
bST 73; control-control; presynch-bST 63; presynch-bST 73 and presynch-control. No 
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differences in pregnancy rates were observed between cows receiving bST at day 63 or day 
73 postpartum. An interaction between presynchronization and bST-treatment indicated that 
pregnancy rates were increased in bST treated cows after presynchronization. Administration 
of bST at initiation of the TAI protocol or at insemination were equally beneficial to 
pregnancy rates (Moreira et al., 2001). 
Approximately 800 cows involved in five different full lactation studies at six 
different locations were utilized to study the effect of dose of rbST (7 different dosages 
ranging from 0 to 3000 mg) in a prolonged released formulation or excipient (control) every 
14 days by either intramuscular or subcutaneous injections, starting at approximately day 60 
post partum and continuing until 74 days prior to expecting calving (Cole et al., 1991). Data 
were analyzed by parity group, route of administration, length of breeding period and level of 
production. Through 305 days in milk, pregnancy rate was reduced 18% in primiparous cows 
treated i.m. with 500 mg bST but was not changed in multiparous cows. 
Twenty-five Holstein cows were injected biweekly with 350 mg of a sustained 
release formulation of bST, and 25 cows were injected daily with 10.3 mg of bST starting 
between week 4 and 5 of lactation and continuing for 280 d (Zhao et al., 1992). Control 
animals (n=24) received biweekly injections of oil microsphere carrier solution. Most 
reproductive traits did not differ between treatments, but the number of days to first service 
increased for bST-treated cows versus the control cows. 
Treatment of 32 postpartum beef cows (Shorthorn x Galloway) with 320 mg of bST 
or carrier oil injected on weeks 2, 4, 6 and 8 post partum did not affect on the number of 
small (3-8 mm) or large (>8 mm) follicles but did increase the estradiol concentration and 
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insulin-like growth factor-I (IGF-I) content of large follicles by nine weeks postpartum 
(Andrade et al., 1996). 
Holstein heifers were treated weekly with 640 mg of rbST or 10 ml saline prior to 
transvaginal ovum pick up performed twice a week. Oocytes were matured and cultured in a 
separate drop for each cow following in-vitro fertilization (IVF) procedure. The total of 
number of follicles and medium sized follicles increased in the bST-treated group. There 
was no statistically significant difference between groups in the number of retrieved oocytes 
and blastocyst per cow (Bols et al., 1998). 
Three experiments were performed to investigate the effect of bST on plasma GH, 
IGF-I and conception rate in cattle. In experiment I lactating Holstein cows (n=18) were 
treated with 0, 100, 200 or 500 mg rbST. Cows had a similar concentration of GH and IGF-I 
before treatment, but treatment with rBST increased serum GH and IGF-I. In experiment 2 
lactating and nonlactating postpartum beef cows (n=18) were treated with 0 or 167 mg of 
rbST at the time of AI. After treatment with rbST, treated cows had greater plasma GH and 
IGF-I than control. In experiment 3, postpartum beef and, dairy cows and heifers from 
different herds were synchronized and treated with 167 mg of rbST or 1 ml of saline at the 
time of AI. Conception rate after rbST treatment increased in 5 out of 6 herds but 
conception rate in heifers was not altered by rbST (Bilby et al., 1999). 
Use of Vitamin A to enhance superovulatory response 
Vitamin A (all-trans-retinol) is afat-soluble vitamin and is well known to regulate 
development, cellular growth and differentiation, and tissue function (Hidalgo et al., 2003). 
Vitamin A is one of the micronutrients that has been implicated as critical to cattle 
reproduction (Ikeda et al., 2005). Vitamin A and its metabolites affect ovarian follicular 
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growth and steroidogenesis, oviductal and uterine environments, immune functions, oocyte 
maturation, and embryo and conceptus development and survival (Eberhardt et al., 1999). A 
precursor of Vitamin A, ~3- carotene, also seems to have a unique role in reproduction 
(Ascarelli et al., 1985) that maybe independent of its function as a precursor to vitamin A 
(Coffey and Britt, 1993). The CL is a steroidogenic tissue that is very rich in ~3- carotene 
(Haliloglu et al., 2002). Supplementation with ~3- carotene and vitamin A has been found to 
enhance embryonic survival in multiovulatory species, including mice (Elmarimi et al., 
1990), rabbits (Besenfelder et al., 1996), sows (Coffey and Britt, 1993) and sheep (Eberhardt 
et al. 1999). 
The effect of vitamin A administration on ovulation rate, number of embryos 
recovered and embryo quality in 48 superovulated beef cows has been investigated (Shaw et 
al., 1995). Cows were synchronized with PGF2a 11 d apart, superovulated with 2 different 
doses of FSH (32.5 mg or 27 mg) over 4 days, and treated with 1 million IU of Vitamin A in 
corn oil with the first injection of FSH, followed by AI and embryo recovery. Ovulation rate, 
determined via transrectal ultrasonography, was not affected by FSH dose or Vitamin A. 
Vitamin A did not affect the total number of embryos recovered, but it did increase the mean 
number of high quality (Grades 1 and 2) and transferable quality (Grades 1, 2 and 3) 
embryos. 
A study was conducted with 50 Holstein cows to examine the levels of Vitamin A 
and (3- carotene in plasma, corpus luteum (CL) and follicular fluid, at different stages of the 
estrous cycle and at 3-6 months of pregnancy (Haliloglu et al., 2002). The highest plasma 
vitamin A levels were observed in proestrus and estrus when follicular activity dominated. 
The vitamin A concentration in the CL and follicular fluid were negatively related to weight 
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and diameter of the CL and diameter of the follicle, respectively. The highest ~3- carotene 
levels in the plasma, CL and follicular fluid were found during pregnancy. 
The effects of TAI and (3- carotene supplementation on reproductive performance of 
dairy cows were studied in three experiments (Arechiga et al., 1998). Experiments 1 and 2 
were conducted during hot months, whereas experiment 3 was conducted during cooler 
months. Cows were fed 0 or 400 mg of ~3-carotene per cow per day for more than 15 days 
before the first AI. Cows were inseminated after 70 d post partum (experiment 1) or 50 d 
postpartum (experiment 2 and 3), and inseminations occurred at observed estrus or following 
the OvSynch program for TAI. Supplemental ~3- carotene had no overall effect on 
reproductive function of cows in Experiment 1; however when only the cows that received ~3-
carotene for > 90 d were considered, the percentage of cows that were pregnant at 120 d 
postpartum was greater. For experiment 2, cows bred at observed estrus exhibited a higher 
pregnancy rate at 90 and 120 d postpartum when they were fed supplemental (3- carotene but 
the inverse was true for the TAI group. During experiment 3, pregnancy rates were 
unaffected by supplementation with (3- carotene. 
Vitamin A and (3- carotene were measured in bovine and porcine plasma, liver, 
corpus luteum, and follicular fluid obtained from abattoirs. Retinol and retinyl esters were 
found in the corpus luteum and follicular fluid of both species. Concentration of ~3- carotene 
was higher in bovine plasma, corpus luteum, and follicular fluid and was lower in porcine 
tissues and fluids (Chew et al., 1984). 
The effect of 5 nmol/1 retinoic acid during in vitro pre maturation and maturation of 
bovine oocyte-cumulus complexes was investigated (Duque et al., 2002). Oocytes were 
28 
aspirated from cows and were either kept in meiotic arrest with 25 µmol/1 of roscovitine and 
matured or allowed to mature in permissive conditions (control). Pre-maturation in the 
presence of retinoic acid improved cytoplasmic competence of in-vitro matured bovine 
oocytes. 
Hidalgo et al. (2003) used 9-cis-retinoic acid during in vitro maturation of bovine 
oocytes and concluded that blastocysts derived from oocytes matured with 9-cis-retinoic acid 
yielded more pregnancies at day 60, suggesting that modification of retinoid metabolism 
affected development and trophectoderm differentiation, and increased the developmental 
competence of the oocytes. 
The impact of treatment with vitamin A or (3- carotene on reproductive characteristics 
has also been studied in species other than cattle. The addition of ~3- carotene to the diet of 
rabbits did not influence body weight, or number of corpora lutea, cysts, oocytes and 
embryos; however, a higher level of vitamin A was positively correlated with an increased 
number of corpora lutea, oocytes and embryos and decreased number of cysts (Besenfelder et 
al., 1996). 
To ascertain if (3-carotene could enhance reproductive performance of pigs, two 
experiments were conducted with both primiparous and multiparous sows. In experiment 1, 
sows were treated on the day of weaning with one i.m. injection of 0, 50, 100 or 200 mg of ~3-
carotene. Sows were checked for estrus daily with boars and were mated at the first estrus 
after weaning. In experiment 2, sows were treated with injections of 200 mg of (3- carotene, 
50,000 ILT of Vitamin A or vehicle on the day of weaning, on the day of matings and 7 days 
after mating. In both experiments sows were fed a diet supplemented with 11,000 IU of 
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vitamin A per kg of body weight. In experiment 1, there was no effect of dose of ~3- carotene 
on the interval from weaning to estrus or on repeat service rate. In experiment 2, injection 
with either (3- carotene or vitamin A increased the number of pigs born alive, and vitamin A 
decreased the number born dead. Litter size was increased (0.6 pigs/litter) when sows were 
injected with either R- carotene or vitamin A at weaning, at estrus and 7 d later (Coffey and 
Britt, 1993). 
Gilts being fed a high energy diet or a control diet were treated i.m. with retinyl-
palmitate (1 X 106 ILJ, vitamin A) or corn oil on d 15 after second estrus. Gilts were mated at 
the third estrus, and the uterus and ovaries were removed on day 11 or 12 after third estrus 
for assessment of the number of CL and number of embryos. Neither diet nor vitamin A 
treatment affected the number of CL; however, Vitamin A exerted a positive effect on the 
number of embryos and embryo development (Whaley et al., 1997). 
Sows received a single injection of 1 x 106 IU of vitamin A dissolved in corn oil at 
weaning or d 0, 2, 6, 10, 13, 19, 30, 70, or 110 after breeding. A single treatment with 
vitamin A did not influence total litter size, pigs born alive, litter weight or piglet weight 
(Pusateri et al., 1999). 
Whaley et al. (2000), hypothesized that administration of vitamin A to gilts before 
ovulation would increase the development of follicles and oocytes and enhance embryo 
survival. Gilts were fed high energy diets starting on day 7 after 2nd estrus, and either corn 
oil or lx 10 6 ILT of vitamin A (retinyl palmitate) was administered (i.m.) at day 15 after the 
second estrus. Gilts were mated naturally at the third estrus and were assigned to midventral 
laparoscopy beginning at 24 to 28, 32 to 36, or 36 to 40 h after onset of estrus when the 
ovulated oocytes and early embryos were recovered from oviducts. Ovaries were removed at 
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those same times to enable aspiration of oocytes from ovarian follicles. Results showed that 
treatment with vitamin A decreased the percentage of germinal vesicle stage oocytes and 
increased the percentage of advanced stage embryos. 
Ewes were superovulated and treated with all-trans retinol, all-trans retinoic acid, 9-
cis retinoic acid, or vehicle on the first and last day of FSH treatments in order to assess the 
effect of retinol on in vitro embryonic survival (Eberhardt et al., 1999). Embryos were 
recovered at the morula stage, cultured in vitro for 96 h, and observed for blastocyst 
formation. The majority of embryos from vehicle-treated animals failed to develop beyond 
the 8-cell stage in comparison with those from all-trans retinol. Ewes treated with all-trans 
retinol exhibited increased embryonic viability and enhanced embryonic development. 
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Abstract 
The objective of this experiment was to investigate bovine somatotropin (bST) and 
Vitamin A as a potential treatment to enhance the number of ovarian follicles that respond to 
superovulation. During phase I, non-lactating Jersey cows (n=36) were randomly assigned to 
one of four treatments (250 mg bST at Day 0, 250 mg bST at Day 8, 1 M units of Vitamin A 
at Day 8, saline at Day 8 [control]). Day 0 was defined as the day of onset of estrus, and 
superovulation treatment was initiated on Day 8 of the estrous cycle. Ultrasonography was 
performed daily to monitor ovarian follicular dynamics and to determine the number of 
ovulations resulting from superovulation. Results revealed that the total number of ovarian 
follicles and superovulatory response was not different among treatments. Phase II utilized 
the same non-lactating Jersey cows used during phase I, and cows received one of three 
treatments (250 mg bST at Day 0, 250 mg at Day 8, saline at Day 8 control) prior to 
superovulation. Artificial insemination was performed, embryos were recovered, and 
embryo quality and stage of development were recorded. Data analysis revealed no effect of 
treatment on the total number of ovarian follicles or on production of transferable quality 
41 
embryos in any of the three replicates. These results indicate that a single treatment with 250 
mg bST or 1 M Units of Vitamin A during the estrous cycle in which superovulation was 
performed is inadequate to enhance superovulatory response. 
*Correspondence: Tel: 1(515) 294-5541, Fax: 1(515) 294-4471 
E-mail address: cryoungs(c~iastate.edu (C.R. Youngs) 
Introduction 
The overall efficiency of the embryo transfer (ET) process depends in large part on 
the success of superovulation of the donor female. Any treatment that would yield one extra 
embryo from each superovulated donor cow would be worth millions of dollars to the 
commercial bovine ET industry. Ovarian follicles acquire responsiveness to gonadotropic 
hormones at the secondary stage, but many of these follicles subsequently undergo atresia. 
Enhanced superovulation maybe achieved by reducing atresia, preventing selection of a 
dominant follicle, or by increasing the number of gonadotropin-responsive follicles. 
Some of the attempts to overcome low rates of response to superovulation and 
variability in the number of embryos recovered have included treatment with bovine 
somatotropin (bST) or vitamin A on different days of the estrous cycle. The mechanism 
through which bST acts is not completely understood, but bST increases GH and IGF-I 
concentrations (Gong et al., 1991). Receptors for IGF-I are found in the ovarian follicles, 
indicating that IGF-I may be involved with follicular growth and development (Moreira et 
al., 2000; Spicer and Echternkamp, 1995). Some researchers have reported that bST alters 
follicular dynamics (De la Sota et al., 1993; Lucy et al., 1993) and increases the number of 
small ovarian follicles (De la Sota et al., 1993; Gong et al., 1991). 
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We hypothesize that superovulatory response may be enhanced by administering, at 
the time of emergence of the first or second follicular wave, compounds that influence 
ovarian follicular development. The objective of this study was to test bST and Vitamin A 
for their ability to increase the number of FSH-responsive ovarian follicles capable of 
responding to superovulation. 
Materials and Methods 
Phase one 
The first phase of this investigation was conducted at the Beef Nutrition Farm of the 
Animal Science Department at Iowa State University, Ames, Iowa and focused on the effect 
of treatment with bovine somatotropin (bST) or vitamin A on follicular dynamics of 
superovulated cows. 
Thirty-six non-lactating predominantly Jersey dairy cows from various sources and 
unknown ages were utilized in this study which was conducted during June and July of 2004. 
An initial ultrasonographic reproductive tract examination was performed to determine the 
cows' reproductive status, and animals were randomly allocated to one of four pens for 
housing during the experiment. Cows were fed grass hay, mineral and water ad libitum, and 
they received corn grain once per day. Estrus was synchronized with 25 mg of prostaglandin 
Fla (PGF2a; ProstamateTM, Agrilabs; St. Joseph, MO). At the time of the PGF2a injection, 
each cow was fitted with a heat detection aid (Kamar° ; Kamar Marketing Group Inc., 
Steamboat Springs, CO). Cows were monitored for heat 2 times per day, and as they 
exhibited estrus (Day 0 was defined as the onset of estrus) were randomly assigned to one of 
four treatments: bST (250 mg Posilac° , Monsanto Corp, St Louis, MO) on Day 0, bST (250 
mg; Posilac®) on Day 8, vitamin A (1 M units;Vital E° +A, Schering Plough Animal Health 
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Corp., Kenilworth, NJ) on Day 8, and saline (0.9% sodium chloride, 5 ml) on Day 8 of the 
estrous cycle. Injections of bST, Vitamin A and saline were administered subcutaneously in 
the neck. Day 0 and Day 8 were specifically chosen as days for treatments because they 
coincide with the start of the first and second follicular wave, respectively. 
Ovaries were monitored daily via ultrasonography using an Aloka 500 SSD- Micrus 
(Aloka CO., LTD, Wallingford, CT) with a 7.5 MHz transrectal transducer (Aloka UST-
5541). All follicles larger than 2 mm were counted, and their diameters were assessed. 
Ovarian follicles were grouped in one of the following size classes according to their 
diameter: small (2 to 3 mm in diameter), medium (4 to 8mm in diameter) and large (greater 
than 8mm in diameter). The number of corpora lutea was also recorded. 
On day 8 of the estrous cycle, superovulation was initiated. A total of 8 intramuscular 
injections of follicle stimulating hormone (FSH; Folltropiri , Bioniche, Belleville, Ontario, 
Canada) was given twice daily over four days at doses of 52 mg, 40 mg, 28 mg, 16 mg of 
FSH per injection, per day, respectively (272 mg total). The cows received an injection of 25 
mg of PGF2a (Prostamate®; Agrilabs) at the time of the seventh and eighth FSH injections, 
and they were fitted with a heat detection aid (Kamar° ) after their seventh FSH injection. 
The cows were monitored for heat thrice per day, and cows exhibiting estrus continued to 
undergo daily ultrasound examination until Day 7. On Day 7 of the estrous cycle 
immediately following superovulation, acount of corpora lutea was performed, cows 
received an injection of PGF2a (ProstaMateTM, 25mg), and phase I was terminated. 
Phase two 
The second phase of the experiment was conducted at Trans Ova Genetics in Sioux 
Center, Iowa beginning in November of 2004. This phase focused on the production of 
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transferable quality embryos (TQEs) from superovulated cows treated with bST on Day 0 or 
Day 8 of the estrous cycle or with saline on Day 8 (control group). Due to a somewhat 
limited number of cows available, the vitamin A treatment was eliminated to enable a greater 
number of cows per treatment in the bST groups. The same animals used in the first phase of 
the study were utilized in the second phase of the experiment. Cows were housed in two 
separate pens, and they received hay and water ad libitum and grain once per day. This phase 
of the study was replicated three times in order to generate statistically meaningful data on 
the effect of the treatments on embryo production. 
Cows were synchronized with a controlled internal drug releasing device (EAZI- 
BREEDTM CIDR®, Pfizer Animal Health, InterAg, Hamilton, New Zealand). At the time of 
CIDR insertion cows also received a 100 µg injection of gonadotropin releasing hormone 
(GnRH, OvacystT'", Phoenix Pharmaceutical Inc., St. Joseph, MO). Seven days after CIDR 
insertion, devices were removed and cows were given a 25 mg injection of PGF2a 
(Lutalyse®, Pfizer Animal Health, New York, NY) as well as an estrus detection patch 
(Estrus Alert° , Western Point, Inc, Merrifield, MN). Heat detection was performed two 
times per day. Once cows were detected in estrus, they were randomly assigned to one of 
three treatments: 250 mg bST on Day 0, 250 mg of bST on Day 8, or 5 ml of saline on Day 8, 
all administered subcutaneously in the neck. Any cow that failed to exhibit estrus could not 
be assigned to treatment and was excluded from that replicate. 
Superovulation was performed exactly as in phase I and was induced starting on Day 
8 of the estrous cycle with FSH (Folltropin ° )being administered twice daily in decreasing 
doses over a 4-day period (272 mg total dose). Concurrent with the seventh and eighth FSH 
injections, luteolysis was induced with 25 mg of PGF2a (Lutalyse®). Cows received a new 
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Estrus Alert's patch after the seventh injection of FSH and were subsequently monitored for 
heat. All cows exhibiting estrus were inseminated two times at 12 h intervals with 2 doses of 
semen at the first artificial insemination (AI) and one dose in the second (AI), using semen 
from a single Holstein sire (Potter, 014HO03597). Any cow that failed to exhibit estrus 
following superovulation was excluded from that replicate. 
Embryos were recovered non surgically on Day 7, and the number of corpora lutea 
was evaluated by rectal palpation. The harvested embryos were evaluated, and the number, 
stage of development, and quality of recovered embryos were recorded. 
Data analysis 
Follicle numbers (total and within size classification) were analyzed using the PROC 
MIXED procedure of statistical analysis software (SAS, 2003). The effect of treatment (bST 
Day 0, bST Day 8, Vitamin A Day 8 and saline Day 8) was tested using cow within treatment 
as the error term. In all analyses, a P value of < .OS was considered a statistically significant 
difference among treatments. Phase II embryo data were analyzed using the PROC GLM 
procedure of SAS. The response variables were number of TQE, number of degenerate 




The total number of ovarian follicles was not different across treatments, except for 
estrous cycle days 104 and 105 (days 104 and 105 correspond to days 4 and 5 of the estrous 
cycle immediately following superovulation) where the total number of ovarian follicles was 
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less (P<.0355) for cows treated with bST on Day 8 than for cows in other treatment groups, 
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Figure 1. The total number of ovarian follicles in non-lactating superovulated Jersey 
cows treated with 250 mg bovine somatotropin (bST) on either Day 0 or Day 
8 of the estrous cycle (Day 0 =onset of estrus), with 1 million units of Vitamin 
A (Vit A) on Day 8 of the estrous cycle, or with saline on Day 8 of the estrous 
cycle. 
The number of small (<4 mm in diameter) ovarian follicles was not different across 
treatments, except for estrous cycle days 9 (P<.0019) and 104 where the number of small 
ovarian follicles was less (P<.0112) for cows treated with bST on Day 8 than for cows in 
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Figure 2. The number of small (< 4 mm in diameter) ovarian follicles in non-lactating 
superovulated Jersey cows treated with 250 mg bovine somatotropin (bST) 
on either Day 0 or Day 8 of the estrous cycle (Day 0 =onset of estrus), with 1 
million units of Vitamin A (Vit A) on Day 8 of the estrous cycle, or with 
saline on Day 8 of the estrous cycle. 
The number of medium (4-8 mm in diameter) ovarian follicles was not different 
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Figure 3. The number of medium (4-8 mm in diameter) ovarian follicles in non-
lactating superovulated Jersey cows treated with 250 mg bovine 
somatotropin (bST) on either Day 0 or Day 8 of the estrous cycle (Day 0 = 
onset of estrus), with 1 million units of Vitamin A (Vit A) on Day 8 of the 
estrous cycle, or with saline on Day 8 of the estrous cycle. 
The number of large (>8 mm in diameter) ovarian follicles was not different across 
treatments, except for estrous cycle day 103 where the total number of large ovarian follicles 
was less (P<.0172) for cows treated with bST on Day 8 than for cows in other treatment 
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Figure 4. The number of large (>8 mm in diameter) ovarian follicles in non-lactating 
superovulated Jersey cows treated with 250 mg bovine somatotropin (bST) 
on either Day 0 or Day 8 of the estrous cycle (Day 0 =onset of estrus), with 1 
million units of Vitamin A (Vit A) on Day 8 of the estrous cycle, or with 
saline on Day 8 of the estrous cycle. 
The total number of corpora lutea (CL) on Day 7 of the estrous cycle immediately 
following superovulation did not differ among treatments and averaged 14.2. 
Phase two 
The total number of ova recovered from superovulated cows averaged 11.7 and was 
not affected by treatment or replicate. However, there was a treatment X replicate interaction 
(P<.0416). These data are presented in Table 1 and Figure 5. The number of TQE averaged 
4.9 and was not affected by treatment or replicate. Similarly, the number of degenerate 
embryos harvested averaged 2.1 and was not affected by treatment or replicate. These data 
are presented in Table 2 and Figure 5. 
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Table 1. Total ova recovered from non-lactating superovulated Jersey cows (Mean ± SEM). 
Treatment* 
saline bST 0 bST 8 
No. of cows 31 29 29 
total ova 11.8 ± 1.5 12.8 ± 1.6 10.3 ± 1.6 
Rep1 14.3±2.6 a'b 18.8±2.6 a 8.6±2.8 b
Rep2 13.1 ±2.5 a'b 10.9 ± 2.8 b 8.6 ± 2.6 b
Rep3 7.9±2.6 b 8.7±2.6 b 13.8±2.6 a,b
* bST 0 and bST 8 denote treatment with 250 mg rbST on Day 0 and Day 8, respectively, of the estrous cycle 
a,b means with unlike superscript differ (p<.OS) 
Table 2. Number of transferable quality embryos (TQE), and degenerate embryos (Deg) 
recovered from non-lactating superovulated Jersey cows (Mean ± SEM). 
Treatment* 
saline bST 0 bST 8 
No. of cows 31 29 29 
TQE 5.8 ±1.0 4.6 ±1.0 4.1 ±1.0 
Deg 2.0±0.6 2.1 ±0.6 2.3±0.6 
* bST 0 and bST 8 denote treatment with 250 mg of rbST on Day 0 and on Day 8, respectively, of the estrous 
cycle 
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Figure 5. The total number of ova, number of transferable quality embryos (TQE), and 
number of degenerate embryos (Deg) recovered from bST-treated and 
saline-treated superovulated Jersey cows. 
To ascertain the nature of the responses to superovulation, afrequency distribution 
chart was created to illustrate the number of cows within treatment groups that produced 
a given number ofTQEs. As shown in Fig. 6, 19/89 flushes failed to yield a TQE. 
Another 5 flushes yielded only a single TQE, meaning that 21 % of flushes gave similar 
or worse results than would have been obtained during embryo recovery from non-
superovulated donors. 
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Figure 6. Distribution of transferable quality embryos (TQEs) recovered from bST-
treated and saline-treated superovulated jersey cows. 
Discussion 
For many years researchers have been trying to improve the overall efficiency of 
embryo transfer by enhancing the number of ovulations and decreasing the inconsistency in 
superovulatory response. Some of the attempts to overcome problems in embryo production 
have included the use of short term (Herrler et al., 1994) or long-term treatment with bST 
(Rieger et al., 1991), and bST combined with estradiol (Cushman et al., 2001). Researchers 
have suggested that GH is involved in ovarian function in cattle, and bST treatment 
significantly increased peripheral GH and IGF-I concentrations (Gong et al., 1991). The 
mechanism through which bST acts in the ovary is not well understood. It could have a 
direct effect at the ovarian level or an indirect effect through IGF-I. Receptors for IGF-I 
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have been detected in ovarian follicles which indicates that IGF-I may affect follicular 
development (Moreira et al., 2000). 
The combination of bST with exogenous FSH treatment has resulted in an increased 
total number of oocytes or embryos (Gong et al., 1993; Herder et al., 1994; Rieger et al., 
1991). Their results suggested that rbST, either directly or through IGF-I, improves the 
ability of follicles to develop in response to exogenous gonadotropin. However, in some 
experiments the number of TQEs remained the same (Herder et al., 1994; Kuehner et al., 
1993; Rieger et al., 1991), a result in agreement with findings from the present study. 
The present study differs from previous experiments because it was the first research 
to use half a dose of bST to enhance superovulatory response. To the best of our knowledge, 
this was the lowest dose of long acting bST used in research for this purpose. The results 
demonstrated that treatment with 250 mg of bST on Day 0 or Day 8 did not affect the number 
of ovarian follicles, the total number of ova, or the number of TQEs recovered from 
superovulated cows. These results disagree with Gong et al. (1996) who showed that 
pretreatment of heifers with 320 mg bST on Day 7 of the estrous cycle enhances the 
superovulatory response via an increased number of ovulations, total number of embryos 
recovered and number of TQEs. Rieger et al. (1991) also reported a tendency in bST 
treatment combined with FSH injections to increase the superovulatory response in heifers. 
One of the problems in superovulatoon is animal to animal variation in response to 
superovulatory compounds (Hasler, 1992). The individual animal response likely had an 
effect on the results of this study. There was a treatment X replicate interaction observed for 
this total number of ova recovered, but the underlying biological reason for the interaction is 
not clear. Perhaps the interaction is due mostly to animal to animal variation in response to 
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superovulation. For example, two animals in the bST Day 0 group in replicate 1 had 
extremely atypical responses (42 and 32 total ova recovered). 
Breed of cattle, age of cattle (Desaulniers et al., 1995) and stage of lactation (Gray et 
al., 1993) could also potentially affect the superovulatory response. One may speculate that 
results from the present study disagree with some of the previous reports in the literature 
because the animals utilized were nonlactating Jersey cows. De la Sota et al. (1993) 
administered daily injections of 25 mg of bST to lactating and non-lactating cows and 
concluded that bST increased the number of follicles in lactating cows but not in non-
lactating cows. However, Cushman et al. (2001) performed a study with nonlactating 
Holstein and Jersey cows treated with bST and estradiol and found the treatment had a 
positive effect on ovulation rate of animals from both breeds. 
The lack of a significant effect of bST on the number of follicles and TQEs in the 
present study could be caused by a short time of exposure to exogenous bST prior to 
exogenous gonadotropin treatment, the dose of bST administered, or by bST injections being 
performed at anon-responsive time in the estrous cycle (Day 0 or Day 8) . Pavlok et al. 
(1996) injected 500 mg bST on the day of estrus (Day 0) and also did not obtain an enhanced 
superovulatory response. Kuehner et al. (1993) reported that treatment with 500 mg bST had 
no effect on the total number of embryos or on the number of TQEs, when heifers were 
treated on Day 4, Day 11 (at the time of the first FSH injection) or Day 15 (at the time of AI). 
However, the overall percentage of TQEs was increased in animals receiving bST on Day 4. 
Gong et al. (1996) observed an increase in the number of embryos recovered and number of 
transferable quality embryos when administering bST on day 7 of the estrous cycle. 
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Moreira et al. (2002) reported an increase in the percentage of TQEs from bST-
treated Holstein donor cows than from control cows receiving a single injection of 500 mg at 
the time of AI. Embryos recovered from bST-treated cows also produced an increased 
pregnancy rate compared with that from control embryos. Gong et al. (1996) treated heifers 
with 320 mg of bST on day 7 of the estrous cycle and observed, also noticed an increase in 
the number of ovulations and number ofTQEs. A dose of bST higher than what was given in 
the present study maybe required for an increase in the ovulatory response in cattle. 
Another factor that could have influenced the present results might be the duration of 
exposure to bST. Heifers that received daily injections of 25 mg of bST for 2 estrous cycles 
had significantly more antral follicles that did untreated control heifers (Gong et al., 1991). 
Contrarily, Andrade et al. (1996) treated beef cows every other week for 4 weeks with a 
single injection of 320 mg of bST and reported that bST did not affect the numbers of small 
or large follicles. Treatment of cows in the present study with half a dose of bST (250 mg) 
did not affect the number of follicles except on days 4 and 5 of estrous cycle immediately 
after superovulation when cows that received bST on Day 8 had fewer ovarian follicles than 
cows in the control group. We can speculate that cows treated with bST on Day 8 may not 
have had enough time for the bST to affect the population of follicles observed during the 
experiment. 
Non-lactating Jersey cows treated with 1 million units of vitamin A on Day 8 of the 
estrous cycle did not exhibit difference in the number of ovarian follicles compared to control 
cows. Our results agree somewhat with those of Shaw et al. (1995) who reported that 
vitamin A given to beef cows during superovulation did not have an altered ovulation rate, 
even though vitamin A increased the mean of number of TQEs. Arechiga et al. (1998) also 
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did not observe any effects on reproductive performance of dairy cows supplemented with ~3-
carotene, except in cases where cows were fed supplemental (3-carotene for > 90 days in 
which case pregnancy rate was enhanced. In an experiment performed in ewes, Eberhardt et 
al. (1999) reported no effect of retinoids administered on the first and last day of FSH 
injections on ovulation rate, fertilization rate or embryo recovery rate. 
Summary 
The results of this study indicate that the use of 250 mg of bST or 1 million unit of 
vitamin A given on Days 0 or Day 8 of the estrous cycle did not increase number of follicles, 
number ofova/embryo recovered, or number of TQEs in non-lactating Jersey cows. The 
animal to animal variation, short period of exposure to the treatments and dose all may have 
affected the outcome of the experiment. Further research into the use of bST or vitamin A on 
different days of the estrous cycle, with higher doses, or for longer durations may elucidate 
whether these compounds can have an affect on follicular dynamics and consequently on 
number of embryos recovered. 
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The experiment described in this thesis is unique because it is the first study to use 
250 mg of long —acting bST (half of a normal dose) with the objective of enhancing 
superovulatory response in cows. It is also one of the few studies that treated nonlactating 
Jersey cows with bST for this purpose. In phase one, four treatments were given (250 mg of 
bST Day 0, 250 mg bST on Day 8, 1 M unit of Vitamin A on Day 8 and saline on Day 8). In 
phase two one treatment (Vitamin A) was removed to enable a greater number of animals per 
treatment. None of the treatments, however, had a consistent positive effect on the number 
of ovarian follicles, the total number of ova, or the number of transferable quality embryos 
recovered from superovulated cows. 
One may speculate that the breed of the animals and lack of lactation may have 
contributed to the non-significant results. The dose of bST could have been too low to have 
an effect, or the dose of FSH could have been higher than optimal to superovulate Jersey 
cows. 
Further research should be done with lower dose of FSH and higher dose of bST on 
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